E. Albert Reece

E. Albert Reece, MD, PhD, MBA, is a Professor at the University of Maryland School of Medicine in the Department of Obstetrics, Gynecology and Reproductive Sciences. He serves as the CARTI Endowed Professor and Director of the Center for Advanced Research Training and Innovation (CARTI), and is a Senior Scientist at the Center for Birth Defects Research. Dr. Reece is a member of the National Academy of Medicine and previously served as Executive Vice President for Medical Affairs and Dean of the School of Medicine.

His educational background includes:

• Bachelor of Science (Magna Cum Laude) from Long Island University
• MD from New York University School of Medicine
• PhD in Biochemistry from the University of the West Indies
• MBA from Temple University
• Residency in Obstetrics and Gynecology at Columbia University Medical Center
• Postdoctoral Fellowship in Maternal-Fetal Medicine at Yale University School of Medicine

Dr. Reece's research focuses on the molecular mechanisms of diabetes-induced birth defects, particularly examining cytoarchitectural changes at the cellular level and biochemical alterations including membrane lipid depletion and oxidative stress. His laboratory employs rat and mouse models to investigate apoptotic pathways, JNK signaling, and protein kinase C isoforms in diabetic embryopathy, with emphasis on developing preventive interventions through vitamin and lipid therapies. His work bridges basic science with clinical applications in prenatal diagnosis and fetal therapy.

Analysis of his recent publications reveals a consistent trajectory toward molecular mechanistic understanding of diabetic embryopathy, with increasing focus on oxidative stress signaling, specific apoptotic pathways, and genetic factors. His research demonstrates the progression from clinical observations of birth defect patterns to detailed cellular and molecular investigations, culminating in targeted therapeutic strategies. The interdisciplinary nature spans obstetrics, biochemistry, developmental biology, and molecular pharmacology.

Scientific recognition includes:

• Distinguished Leadership Award (2009)
• Berson Medical Alumni Achievement Award in Health Sciences (2010)
• Distinguished Service Award from Loma Linda University (2010)
• Election to the National Academy of Medicine

Dr. Reece has directed NIH-funded multi-million dollar research programs and served on influential committees including the FDA, NIH, Institute of Medicine, and March of Dimes Scientific Advisory Committee on Prematurity. His leadership extended to chairing the Association of American Medical Colleges Council of Deans and developing the ANGELS telemedicine system for rural obstetrical care. He has mentored numerous faculty and established performance-based incentive models for academic medicine.

He directs the Center for Advanced Research Training and Innovation (CARTI), fostering interdisciplinary research in maternal-fetal health, and co-founded embryofetoscopy techniques for early prenatal diagnosis and potential fetal therapy. His laboratory group maintains active investigations into diabetes-induced embryopathy mechanisms while translating findings into clinical practice.